Skip to main content
HLB PHARMACEUTICAL CO., LTD. logo

HLB PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 047920 ISIN · KR7047920004 KO Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2025-02-11 Earnings Release
Country KR South Korea
Listing KO 047920

About HLB PHARMACEUTICAL CO., LTD.

https://www.hlbpharma.co.kr/eng/

HLB PHARMACEUTICAL CO., LTD. is a biopharmaceutical company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company specializes in the production of quasi-drugs, such as alcohol swabs for disinfecting wounds and sterilizing medical devices. Its portfolio also includes prescription medications like skeletal muscle relaxants. A key focus of its research and development activities is the discovery and advancement of new peptide-based drugs. As part of the broader HLB Group, it contributes to a diverse portfolio that spans pharmaceuticals, medical devices, and diagnostics.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from HLB Pharmaceutical regarding a significant change in financial performance (revenue/profit structure). It provides a summary table of financial results (revenue, operating profit, net income) comparing the current fiscal year to the previous one, indicating a turnaround to profit. This type of disclosure is a standard regulatory requirement for listed companies to announce preliminary financial results before the final audited report is published. It fits the definition of an Earnings Release (ER) as it provides key financial highlights and the reasons for the change. FY 2024
2025-02-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the shareholding status, changes in ownership, and collateral agreements of major shareholders (HLB Life Science and related parties) in HLB Pharmaceutical. This falls under the category of Major Shareholding Notification.
2025-01-22 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the upcoming Annual General Meeting (AGM). It specifies the record date (2024-12-31) and the purpose (holding the 27th Annual General Meeting). Since it is a regulatory notification regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under general regulatory filings.
2024-12-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the shareholding status, changes in ownership, and contractual relationships (such as stock collateral agreements) of major shareholders. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-12-03 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for HLB Pharmaceutical Co., Ltd. covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial statements, business operations, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of major shareholders and special related parties of HLB Pharmaceutical Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and related contractual changes.
2024-10-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.